A case of sarcomatoid carcinoma of the bladder is reported herein. Immunohistochemical staining with human pancytokeratin antibody was negative, while vimentin staining was strongly positive, suggesting a diagnosis of sarcoma of the bladder. Further immunohistochemical analysis revealed positivity for AE1/AE3 cytokeratins, permitting a correct diagnosis of sarcomatoid carcinoma of the bladder. It can be difficult to distinguish between sarcomatoid carcinoma, undifferentiated carcinoma and sarcoma, particularly if the biopsy specimens are of small size. In rare cases, sarcomatoid tumors may express epithelial markers different from those revealed by human pancytokeratin staining.
Introduction
Sarcomatoid carcinoma is a rare, malignant, spindle cell neoplasia in which epithelial differentiation can be demonstrated by immunohistochemical or ultrastructural studies. It may arise in different sites, such as the digestive tract [1, 2] , kidney [3] , lung [4] and urinary bladder [5] [6] [7] . The most common clinical presentation is gross hematuria. Prognosis is poor since 66% of the patients develop metastases within 1 year from diagnosis [8] .
Histological and immunohistochemical features of this neoplasm are variable and do not always allow an exact identification, making it difficult to distinguish between sarcomatoid carcinoma, carcinosarcoma and sarcoma, particularly if biopsy specimens are small in size and lack an evident epithelial component [9, 10] .
Case Report
A 70-year-old woman was admitted to our hospital due to gross hematuria. Routine hematological examinations were within normal limits. Chest X-ray was normal. Upon abdominal ultrasound, a solid lesion of the left lateral wall of the bladder, 5 cm in diameter, was detected. The lesion was confirmed by IVP, showing a normal upper urinary tract. Abdominal CT scan revealed a solid lesion deeply infiltrating the vesical wall ( fig. 1) . Lymph node or distant metastases were not evident.
A single solid tumor of the left wall involving the left ureteric orifice was evident upon pre-operative cystoscopy. The pathological examination of TUR biopsy specimens revealed an 'undifferentiated carcinoma' deeply infiltrating the muscular layers.
Radical cystectomy with a Mainz-II diversion was immediately performed.
Cappello/Aragona/Serretta/Randazzo/ Melloni Microscopic examination revealed the presence of anaplastic and atypical spindle cells, growing in a sarcoma-like fashion. Hyperchromatic nuclei, nucleolar prominence and high mitotic rate with atypical pictures were present in many fields ( fig. 2) . The muscular layers were infiltrated by neoplastic tissue. Immunohistochemical staining with streptavidin-biotin complex (LSAB2, DAKO) was performed, using the following antibodies at 1:50 dilution: human pancytokeratin, vimentin, actin, desmin, CD34, FVIII-VWF, HMB45 and EMA (table 1) . Human cytokeratin was negative, while the neoplasm showed strong vimentin positivity, thus suggesting a diagnosis of sarcoma. All other markers were absent. In order to better immunocharacterize the neoplasm, we also searched for the presence of AE1/ AE3 cytokeratins, which were strongly positive ( fig. 3) , allowing a definite diagnosis of sarcomatoid carcinoma.
Two months later, a lesion of the small bowel was detected. The patient was submitted to ileal resection. The histological examination revealed microscopic and immunohistochemical features similar to those of the bladder (fig. 4) . Doubts still exist if this lesion was a metastasis or another primary sarcomatoid tumor. The patient died 3 months later due to pelvic recurrence and multiple lung metastases.
Discussion
High-grade transitional cell carcinoma is associated with squamous, glandular or spindled metaplasia in 20-30% of cases. In 1993, Reuter [6] stated that only when metaplasia involved more than 90% of the tissue can these tumors be termed 'adenocarcinoma', 'squamous carcinoma' or 'sarcomatoid carcinoma'. According to this definition, sarcomatoid carcinoma of the bladder is a rare urinary tumor with an incidence of 0.3% of all bladder tumors [8] . The histogenesis of sarcomatoid carcinoma is uncertain and the nomenclature is not consistent. Frequently, sarcomatoid carcinoma and carcinosarcoma are used synonymously. Even if nowadays there is no practical advantage in differentiating sarcomatoid tumors from carcinosarcomas, in the future this distinction could imply a different therapeutic approach. Sarcomatoid carcinoma may be confused with pure sarcoma. The latter does not usually stain for epithelial markers. However, cytokeratin immunoreactivity may be present incidentally in smooth muscle tumors. In smooth muscle, however, keratin expression is never seen in the absence of desmin and vimentin. The use of a wide panel of antibodies to intermediate filament proteins may avoid erroneous diagnosis. Usually, sarcomatoid tumors show strong positivity to vimentin and human cytokeratins, as recently demonstrated in 14 cases by Ikegami et al. [11] . Our diagnosis of sarcomatoid carcinoma was performed using a wide panel of cytokeratin antibodies. Particularly 'human pancytokeratin' antibody is specific for 1, 5, 6, 8, 10, 14 and 18 cytokeratins, while 'AE1/AE3 cytokeratin' antibody recognizes 2, 4, 5, 6, 8, 9, 10, 14, 15, 16 and 19 cytokeratins. The spectrum of the latter is different and wider. The practical relevance of our observation lies in the evidence that sometimes bladder carcinoma may express epithelial markers different from those commonly used. Using human pancytokeratin only, the immunohistochemical diagnosis would have been that of sarcoma of the bladder.
Ikegami et al. [11] , in their experience, reported that the areas of transition between carcinomatoid and sarcomatoid elements were focally evident in each tumor. Epithelial antigens were expressed in all sarcomatoid tumors even if the staining pattern varied from case to case. Moreover, cell adhesion molecules had a higher expression rate in the carcinomatoid than in the sarcomatoid component.
Often, the preoperative histological diagnosis at TUR biopsy is not that of sarcomatoid tumor [12] . In our case, the diagnosis was that of undifferentiated carcinoma.
Lopez-Beltan et al. [13] at the Mayo Clinic recently reviewed 26 cases of sarcomatoid tumors of the bladder. Pure spindle cell carcinoma without any apparent transitional cell carcinoma was detected in 19% of their cases. All the patients had advanced neoplasm at diagnosis and 81% died of sarcomatoid tumor at a mean of 10 months.
In patients with vesical sarcomatoid tumors, a conservative approach rarely provides prolonged survivals. Chemotherapy does not seem to give any additional advantage in survival and progression-free interval. Thus the treatment of patients with sarcomatoid tumors must be aggressive and these tumors must be promptly identified.
Conclusions
It can be difficult to distinguish between sarcomatoid carcinoma, undifferentiated carcinoma and sarcoma, particularly if the biopsy specimens are of small size. Usually, at immunohistochemical examination sarcomatoid tumors show a strong positivity to vimentin and human pancytokeratins. In rare cases, sarcomatoid tumors may express epithelial markers different from those commonly used. A wide panel of cytokeratins must be used and also AE1/AE3 cytokeratin positivity can help to avoid an erroneous diagnosis of sarcoma of the bladder. L'esame immunoistochimico è risultato inizialmente negativo per la pancitocheratina umana e positivo per la vimentina suggerendo la diagnosi di sarcoma della vescica. Un'ulteriore analisi immunoistochimica ha però dimostrato la marcata positività per le citocheratine AE1/ AE3 permettendo così la corretta diagnosi di carcinoma sarcomatoide della vescica.
Può essere talora difficile distinguere tra carcinoma sarcomatoide, carcinoma indifferenziato e sarcoma, particolarmente se i prelievi bioptici sono di piccole dimensioni. In rari casi, i tumori sarcomatoidi possono esprimere markers epiteliali differenti da quelli rappresentati dalla pancitocheratina umana.
